HEAT-TREATMENT OF LEUKEMIC-CELL LINES CAN INCREASE THEIR SENSITIVITY TO NK LYSIS

被引:4
|
作者
SCOTT, JE [1 ]
DAWSON, JR [1 ]
机构
[1] DUKE UNIV,MED CTR,DEPT IMMUNOL,DURHAM,NC 27710
关键词
D O I
10.1006/cimm.1995.1129
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The effect of stress on target cell susceptibility to human natural killer cell-mediated lysis was examined. Targets were incubated at 37, 42, or 45 degrees C for 1 hr and then tested for NK sensitivity in chromium-release assays, The T cell target JURKAT displayed minor increases in susceptibility to NK lysis with 42 degrees C pretreatment (20-50% increases) and dramatic increases in lysability with 45 degrees C pretreatment (100-300% increase) compared to control, In contrast, lysis of the NK prototypic target K562 is not increased after 42 or 45 degrees C pretreatment, Kinetic studies indicated an optimal NK sensitivity enhancement time of 1 hr at 45 degrees C for JURKAT. Inhibition of target cell protein synthesis by emetine pretreatment does not produce an increase in susceptibility to NK lysis, JURKAT cells pretreated with sodium arsenite exhibited a comparable increase in NK sensitivity to the heat treatments, Cold target inhibition assays suggest that the increase in sensitivity after heat treatment is at a postbinding stage, This was exemplified by the increased sensitivity of JURKAT, but not K562, to lysis mediated by isolated rat NK granules, These results indicate that a heat-sensitive, de novo protein synthesis-independent defense mechanism against lysis may exist in some tumors, altering their susceptibility to lysis by NK cells. (C) 1995 Academic Press, Inc.
引用
收藏
页码:296 / 302
页数:7
相关论文
共 50 条
  • [31] IMMUNOCYTOCHEMICAL EVALUATION OF ABL-GENE PRODUCTS IN LEUKEMIC-CELL LINES
    KITAZAWA, S
    MAEDA, S
    SUGIYAMA, T
    [J]. MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1990, 7 (01): : 35 - 41
  • [32] EFFECTS OF ALKYL-LYSOPHOSPHOLIPIDS ON PHOSPHATIDYLCHOLINE BIOSYNTHESIS IN LEUKEMIC-CELL LINES
    VOGLER, WR
    OLSON, AC
    KISS, Z
    SHOJI, M
    KUO, JF
    [J]. JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1988, 65 (04) : 516 - 516
  • [33] ESTABLISHMENT OF A GROUP OF MURINE LEUKEMIC-CELL LINES AND INVESTIGATION OF THEIR BIOLOGICAL CHARACTERISTICS
    WAN, JH
    ZHANG, SJ
    MI, JX
    QI, SL
    WU, KF
    GAN, F
    YANG, BQ
    XU, LJ
    XU, LZ
    [J]. SCIENCE IN CHINA SERIES B-CHEMISTRY, 1989, 32 (09): : 1087 - 1098
  • [34] THE RELATIONSHIP BETWEEN MULTIDRUG RESISTANCE AND RESISTANCE TO NATURAL-KILLER-CELL AND LYMPHOKINE-ACTIVATED KILLER-CELL LYSIS IN HUMAN LEUKEMIC-CELL LINES
    TREICHEL, RS
    OLKEN, S
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (02) : 305 - 310
  • [35] MULTIDRUG-RESISTANT (MDR) LEUKEMIC-CELL LINE IS RESISTANT TO NK CYTOTOXIC MECHANISMS
    TREICHEL, RS
    [J]. FASEB JOURNAL, 1995, 9 (04): : A791 - A791
  • [36] ANTIMICROTUBULE AGENTS INDUCE POLYPLOIDIZATION OF HUMAN LEUKEMIC-CELL LINES WITH MEGAKARYOCYTIC FEATURES
    VANDERLOO, B
    HONG, Y
    HANCOCK, V
    MARTIN, JF
    ERUSALIMSKY, JD
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (10) : 621 - 629
  • [37] BIOCHEMICAL-CHARACTERIZATION OF FLUOROPYRIMIDINE-RESISTANT MURINE LEUKEMIC-CELL LINES
    MULKINS, MA
    HEIDELBERGER, C
    [J]. CANCER RESEARCH, 1982, 42 (03) : 965 - 973
  • [38] ENDONUCLEASE ACTIVITY AND INDUCTION OF DNA FRAGMENTATION IN HUMAN MYELOGENOUS LEUKEMIC-CELL LINES
    YANAGISAWASHIOTA, F
    SAKAGAMI, H
    KURIBAYASHI, N
    IIDA, M
    SAKAGAMI, T
    TAKEDA, M
    [J]. ANTICANCER RESEARCH, 1995, 15 (02) : 259 - 265
  • [39] GROWTH-INHIBITION OF HUMAN LEUKEMIC-CELL LINES BY THE PHENOTHIAZINE DERIVATIVE FLUPHENAZINE
    SCHLEUNING, M
    BRUMME, V
    WILMANNS, W
    [J]. ANTICANCER RESEARCH, 1993, 13 (03) : 599 - 602
  • [40] LYMPHOCYTE DERIVED DIFFERENTIATION INDUCING FACTORS FOR HUMAN MYELOID LEUKEMIC-CELL LINES
    OLSSON, IL
    BREITMAN, TR
    SARNGADHARAN, MG
    GALLO, RC
    [J]. CLINICAL RESEARCH, 1981, 29 (02): : A521 - A521